次世代がん診断の世界市場規模調査＆予測、技術別、用途別、がんタイプ別、機能別、地域別分析、2022-2029年

次世代がん診断の世界市場は、2021年に約79億8,000万米ドルと評価され、予測期間2022-2029年には12.38%以上の健全な成長率で成長すると予測されています。

がん診断とは、患者の悪性腫瘍の存在を特定するために、さまざまなタンパク質、バイオマーカー、症状などを調べる手法です。がんを特定する方法には、特定の技術や診断ツールを広範囲に使用することが含まれます。次世代がん診断市場は、がんの発生率の増加、クラスターチップ技術の開発、がん管理におけるCTCの潜在的な応用などの要因によって拡大しています。

国際がん研究機関（IARC）の推計によると、世界のがん罹患率の増加は、2021年の190万件から2040年には2,750万件になると推定されており、がん罹患率の上昇が市場成長を促進しています。さらに、予防医学＆コンパニオン診断の需要の高まりや、がん医学の研究開発活動の高まりとともに、製品や技術開発に対するFDA承認の高まりは、市場に有利な成長をもたらしています。例えば、2022年8月、次世代シーケンサーに基づくがん診断薬の検証および規制審査プロセスを強化するパイロットプロジェクトを使用して、米国食品医薬品局との官民パートナーシップである医療機器イノベーションコンソーシアム（MDIC）は、医療機器規制科学の進歩に取り組んでおり、月曜日に、体細胞参照サンプル（SRS）イニシアチブ（NGS）の次の段階を開始したと発表しました。しかし、新規検査の実施には高価なラボのセットアップが必要であるため、市場の成長を阻害する可能性があります。

次世代がん診断の世界市場調査において考慮した主な地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、ブランド製品の優位性とこの地域の疾患有病率の増加により、売上高で市場を独占しています。一方、アジア太平洋地域は、老年人口や対象人口の増加、製品開拓のための共同研究の増加、主要企業の地域的拡大、政府機関や非営利団体の市場参入などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や技術提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • 次世代がん診断市場、地域別、2019-2029年
  • 次世代がん診断市場、技術別、2019-2029年
  • 次世代がん診断市場、用途別、2019-2029年
  • 次世代がん診断市場、がん種別、2019-2029年
  • 次世代がん診断市場、機能別、2019-2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 次世代がん診断の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 次世代がん診断の世界市場力学

• 次世代がん診断市場のインパクト分析（2019年～2029年）
  • 市場促進要因
    • がん罹患率の増加
    • クラスターチップ技術の開発とCTCのがん管理への応用の可能性
  • 市場の課題
    • 新規のテストを実施するために、高価な実験室が必要です
  • 市場機会
    • 予防医学・コンパニオン診断の需要拡大
    • がん治療薬の研究開発活動の活発化

第4章 次世代がん診断の世界市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 主な投資機会
• 主要成功戦略
• 業界関係者見通し
• アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 次世代がん診断の世界市場：技術別

• マーケットスナップショット
• 次世代がん診断の世界市場：技術別、実績 - ポテンシャル分析
• 次世代がん診断の世界市場技術別推定・予測2019-2029
• 次世代がん診断市場、サブセグメント分析
  • 次世代シーケンシング
  • qPCR &マルチプレキシング
  • ラボオンチップ（LOAC）・逆転写酵素PCR（RT-PCR）
  • プロテインマイクロアレイ
  • DNAマイクロアレイ

第7章 次世代がん診断の世界市場：用途別

• マーケットスナップショット
• 次世代がん診断の世界市場：用途別、実績- ポテンシャル分析
• 次世代がん診断の世界市場推定・予測（用途別） 2019-2029
• 次世代がん診断市場、サブセグメント分析
  • バイオマーカー開発
  • CTC分析
  • プロテオーム解析
  • エピジェネティック解析
  • 遺伝子解析

第8章 次世代がん診断の世界市場：がんタイプ別

• マーケットスナップショット
• 次世代がん診断の世界市場：がんタイプ別、実績 - ポテンシャル分析
• 次世代がん診断の世界市場、がんタイプ別推定・予測2019-2029
• 次世代がん診断市場、サブセグメント分析
  • 肺がん
  • 乳がん
  • 大腸がん
  • 子宮頸がん
  • その他

第9章 次世代がん診断の世界市場：機能別

• マーケットスナップショット
• 次世代がん診断の世界市場：機能・実績 - ポテンシャル分析
• 次世代がん診断の世界市場機能別推定・予測2019年～2029年
• 次世代がん診断市場、サブセグメント分析
  • 治療モニタリング
  • コンパニオン診断薬
  • プログノスティックス
  • がん検診
  • リスク分析

第10章 次世代がん診断の世界市場：地域別分析

• 次世代がん診断市場、地域別マーケットスナップショット
• 北米
  • 米国
    • 技術別の推定・予測、2019年～2029年
    • アプリケーション別の推定・予測、2019年～2029年
    • がんタイプ別の推定・予測、2019年～2029年
    • 機能別の推定・予測、2019年～2029年
  • カナダ
• 欧州の次世代がん診断市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋の次世代がん診断市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの次世代がん診断市場スナップショット
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域
• 世界のその他の地域

第11章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Janssen Global Services, LLC
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Koninklijke Philips N.V.
  • Abbott Laboratories
  • GE Healthcare
  • Thermo Fisher Scientific, Inc
  • Agilent Technologies（Dako）Inc.
  • Illumina, Inc.
  • Opko Health, Inc

第12章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Next Generation Cancer Diagnostics Market, report scope
• TABLE 2. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
• TABLE 4. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
• TABLE 5. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
• TABLE 6. Global Next Generation Cancer Diagnostics Market estimates & forecasts by Function 2019-2029 (USD Billion)
• TABLE 7. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Next Generation Cancer Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. Global Next Generation Cancer Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. U.S. Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. Canada Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. UK Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. Germany Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. France Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Italy Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. Spain Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. RoE Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. China Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. India Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. Japan Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. South Korea Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. Australia Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. RoAPAC Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Brazil Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. Mexico Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. RoLA Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Next Generation Cancer Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 69. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. Row Next Generation Cancer Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 71. List of secondary sources, used in the study of global Next Generation Cancer Diagnostics Market
• TABLE 72. List of primary sources, used in the study of global Next Generation Cancer Diagnostics Market
• TABLE 73. Years considered for the study
• TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Next Generation Cancer Diagnostics Market, research methodology
• FIG 2. Global Next Generation Cancer Diagnostics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Next Generation Cancer Diagnostics Market, key trends 2021
• FIG 5. Global Next Generation Cancer Diagnostics Market, growth prospects 2022-2029
• FIG 6. Global Next Generation Cancer Diagnostics Market, porters 5 force model
• FIG 7. Global Next Generation Cancer Diagnostics Market, pest analysis
• FIG 8. Global Next Generation Cancer Diagnostics Market, value chain analysis
• FIG 9. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Next Generation Cancer Diagnostics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Next Generation Cancer Diagnostics Market, regional snapshot 2019 & 2029
• FIG 15. North America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Next Generation Cancer Diagnostics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Next Generation Cancer Diagnostics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Next Generation Cancer Diagnostic Market is valued at approximately USD 7.98 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 12.38% over the forecast period 2022-2029. Cancer diagnostics is a technique that looks for various proteins, biomarkers, and symptoms to identify the presence of malignant tumours in patients. The method of identifying cancer involves the extensive use of specific technologies and diagnostic tools. The Next Generation Cancer Diagnostic market is expanding because of factors such as the increasing incidence of Cancer, the development of cluster chip technology and potential applications of CTC in cancer management.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, rising FDA approval for product and technological development along with rising demand for preventive medicine & companion diagnostics and rising cancer medicine research and development activities is creating lucrative growth in the market. For instance, in August 2022, using a pilot project to enhance the validation and regulatory review process for cancer diagnostics based on next-generation sequencing, the Medical Device Innovation Consortium (MDIC), a public-private partnership with US Food and Drug Administration is working to advance medical device regulatory science, announced on Monday that it has begun the next phase of the Somatic Reference Samples (SRS) Initiative (NGS). However, the requirement of an expensive laboratory set-up for the implementation of novel tests may halt market growth.

The key regions considered for the Global Next Generation Cancer Diagnostic Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

• Janssen Global Services, LLC
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Koninklijke Philips N.V.
• Abbott Laboratories
• GE Healthcare
• Thermo Fisher Scientific, Inc
• Agilent Technologies (Dako) Inc
• Illumina, Inc.
• Opko Health, Inc.

Recent Developments in the Market:

• In February 2022, Becton and Dickinson Corporation (BD) procured Cytogons in order to secure exclusive access to cutting-edge assays licensed from the EuroFlow Consortium and to solidify BD's position as the industry leader in molecular oncology diagnostics.

Global Next Generation Cancer Diagnostic Market Report Scope:

• Historical Data 2019-2020-2021
• Base Year for Estimation 2021
• Forecast period 2022-2029
• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered Technology, Application, Cancer Type, Function, Region
• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technologyofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Technology:

• Next-Generation Sequencing
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
• Protein Microarrays
• DNA Microarrays

By Application:

• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis

By Cancer Type:

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

By Function:

• Therapeutic Monitoring
• Companion Diagnostics
• Prognostics
• Cancer Screening
• Risk Analysis

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Next Generation Cancer Diagnostics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Next Generation Cancer Diagnostics Market, by Technology, 2019-2029 (USD Billion)
  • 1.2.3. Next Generation Cancer Diagnostics Market, by Application, 2019-2029 (USD Billion)
  • 1.2.4. Next Generation Cancer Diagnostics Market, by Cancer Type, 2019-2029 (USD Billion)
  • 1.2.5. Next Generation Cancer Diagnostics Market, by Function, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Next Generation Cancer Diagnostics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Next Generation Cancer Diagnostics Market Dynamics

• 3.1. Next Generation Cancer Diagnostics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of Cancer
    • 3.1.1.2. Development of cluster chip technology and potential applications of CTC in cancer management
  • 3.1.2. Market Challenges
    • 3.1.2.1. Requirement of expensive laboratory set-up for implementation of novel tests
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising demand for preventive medicine & companion diagnostics
    • 3.1.3.2. Rising cancer medicine research and development activities

Chapter 4. Global Next Generation Cancer Diagnostics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Next Generation Cancer Diagnostics Market, by Technology

• 6.1. Market Snapshot
• 6.2. Global Next Generation Cancer Diagnostics Market by Technology, Performance - Potential Analysis
• 6.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
• 6.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
  • 6.4.1. Next-Generation Sequencing
  • 6.4.2. qPCR & Multiplexing
  • 6.4.3. Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
  • 6.4.4. Protein Microarrays
  • 6.4.5. DNA Microarrays

Chapter 7. Global Next Generation Cancer Diagnostics Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Next Generation Cancer Diagnostics Market by Application, Performance - Potential Analysis
• 7.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 7.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
  • 7.4.1. Biomarker Development
  • 7.4.2. CTC Analysis
  • 7.4.3. Proteomic Analysis
  • 7.4.4. Epigenetic Analysis
  • 7.4.5. Genetic Analysis

Chapter 8. Global Next Generation Cancer Diagnostics Market, by Cancer Type

• 8.1. Market Snapshot
• 8.2. Global Next Generation Cancer Diagnostics Market by Cancer Type, Performance - Potential Analysis
• 8.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
• 8.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
  • 8.4.1. Lung Cancer
  • 8.4.2. Breast Cancer
  • 8.4.3. Colorectal Cancer
  • 8.4.4. Cervical Cancer
  • 8.4.5. Others

Chapter 9. Global Next Generation Cancer Diagnostics Market, by Function

• 9.1. Market Snapshot
• 9.2. Global Next Generation Cancer Diagnostics Market by Function, Performance - Potential Analysis
• 9.3. Global Next Generation Cancer Diagnostics Market Estimates & Forecasts by Function 2019-2029 (USD Billion)
• 9.4. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
  • 9.4.1. Therapeutic Monitoring
  • 9.4.2. Companion Diagnostics
  • 9.4.3. Prognostics
  • 9.4.4. Cancer Screening
  • 9.4.5. Risk Analysis

Chapter 10. Global Next Generation Cancer Diagnostics Market, Regional Analysis

• 10.1. Next Generation Cancer Diagnostics Market, Regional Market Snapshot
• 10.2. North America Next Generation Cancer Diagnostics Market
  • 10.2.1. U.S. Next Generation Cancer Diagnostics Market
    • 10.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
    • 10.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 10.2.1.3. Cancer Type breakdown estimates & forecasts, 2019-2029
    • 10.2.1.4. Function breakdown estimates & forecasts, 2019-2029
  • 10.2.2. Canada Next Generation Cancer Diagnostics Market
• 10.3. Europe Next Generation Cancer Diagnostics Market Snapshot
  • 10.3.1. U.K. Next Generation Cancer Diagnostics Market
  • 10.3.2. Germany Next Generation Cancer Diagnostics Market
  • 10.3.3. France Next Generation Cancer Diagnostics Market
  • 10.3.4. Spain Next Generation Cancer Diagnostics Market
  • 10.3.5. Italy Next Generation Cancer Diagnostics Market
  • 10.3.6. Rest of Europe Next Generation Cancer Diagnostics Market
• 10.4. Asia-Pacific Next Generation Cancer Diagnostics Market Snapshot
  • 10.4.1. China Next Generation Cancer Diagnostics Market
  • 10.4.2. India Next Generation Cancer Diagnostics Market
  • 10.4.3. Japan Next Generation Cancer Diagnostics Market
  • 10.4.4. Australia Next Generation Cancer Diagnostics Market
  • 10.4.5. South Korea Next Generation Cancer Diagnostics Market
  • 10.4.6. Rest of Asia Pacific Next Generation Cancer Diagnostics Market
• 10.5. Latin America Next Generation Cancer Diagnostics Market Snapshot
  • 10.5.1. Brazil Next Generation Cancer Diagnostics Market
  • 10.5.2. Mexico Next Generation Cancer Diagnostics Market
  • 10.5.3. Rest of Latin America Next Generation Cancer Diagnostics Market
• 10.6. Rest of The World Next Generation Cancer Diagnostics Market

Chapter 11. Competitive Intelligence

• 11.1. Top Market Strategies
• 11.2. Company Profiles
  • 11.2.1. Janssen Global Services, LLC
    • 11.2.1.1. Key Information
    • 11.2.1.2. Overview
    • 11.2.1.3. Financial (Subject to Data Availability)
    • 11.2.1.4. Product Summary
    • 11.2.1.5. Recent Developments
  • 11.2.2. Novartis AG
  • 11.2.3. F. Hoffmann-La Roche Ltd
  • 11.2.4. Koninklijke Philips N.V.
  • 11.2.5. Abbott Laboratories
  • 11.2.6. GE Healthcare
  • 11.2.7. Thermo Fisher Scientific, Inc
  • 11.2.8. Agilent Technologies (Dako) Inc.
  • 11.2.9. Illumina, Inc.
  • 11.2.10. Opko Health, Inc

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption